Medical management of ulcerative colitis.

[1]  M. Kamm,et al.  Long‐term results of low‐dose intravenous ciclosporin for acute severe ulcerative colitis , 2003, Alimentary pharmacology & therapeutics.

[2]  R. Playford,et al.  Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. , 2003, The New England journal of medicine.

[3]  A. Forbes,et al.  Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial , 2003, Gut.

[4]  D. Jewell,et al.  The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review , 2002, Gut.

[5]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[6]  M. Sans,et al.  Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. , 2000, Gastroenterology.

[7]  K. Abrams,et al.  Colorectal cancer prevention in ulcerative colitis: a case‐control study , 2000, Alimentary pharmacology & therapeutics.

[8]  E. Scott,et al.  Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease , 2000 .

[9]  B. Rembacken,et al.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial , 1999, The Lancet.

[10]  D. Jewell,et al.  Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? , 1998, European journal of gastroenterology & hepatology.

[11]  S. Stephens,et al.  Treatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571 , 1997 .

[12]  S. Targan,et al.  A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. , 1997, The American journal of gastroenterology.

[13]  A. Amorosi,et al.  Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. , 1997, The American journal of gastroenterology.

[14]  J. Marshall,et al.  Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. , 1997, Gut.

[15]  S Gallivan,et al.  Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. , 1997, Journal of clinical pathology.

[16]  D. Jewell,et al.  Predicting outcome in severe ulcerative colitis. , 1996, Gut.

[17]  A. Lavy,et al.  Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. , 1996, Gastroenterology.

[18]  R. Newcombe,et al.  Transdermal nicotine as maintenance therapy for ulcerative colitis. , 1995, The New England journal of medicine.

[19]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[20]  A. Axon,et al.  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. , 1992, BMJ.